Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from BASIC SCIENCE INVESTIGATIONS

  • You have access
    Characterization of 18F-FPyKYNE-Losartan for Imaging AT1 Receptors
    Maryam Hachem, Mario Tiberi, Basma Ismail, Chad R. Hunter, Natasha Arksey, Tayebeh Hadizad, Rob S. Beanlands, Robert A. deKemp and Jean N. DaSilva
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1612-1617; DOI: https://doi.org/10.2967/jnumed.115.170951
  • You have access
    Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies
    Matthijs C.F. Cysouw, Gerbrand Maria Kramer, Otto S. Hoekstra, Virginie Frings, Adrianus Johannes de Langen, Egbert F. Smit, Alfons J.M. van den Eertwegh, Daniela E. Oprea-Lager and Ronald Boellaard
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1642-1649; DOI: https://doi.org/10.2967/jnumed.116.173831
  • You have access
    Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation
    Nimali P. Withana, Toshinobu Saito, Xiaowei Ma, Megan Garland, Changhao Liu, Hisanori Kosuge, Myriam Amsallem, Martijn Verdoes, Leslie O. Ofori, Michael Fischbein, Mamoru Arakawa, Zhen Cheng, Michael V. McConnell and Matthew Bogyo
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1583-1590; DOI: https://doi.org/10.2967/jnumed.115.171553
  • You have access
    Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent
    Hiroshi Wakabayashi, Rudolf A. Werner, Nobuyuki Hayakawa, Mehrbod S. Javadi, Chen Xinyu, Ken Herrmann, Steven P. Rowe, Constantin Lapa and Takahiro Higuchi
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1625-1628; DOI: https://doi.org/10.2967/jnumed.116.172718
  • You have access
    Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy
    Benjamin M. Larimer, Eric Wehrenberg-Klee, Alexander Caraballo and Umar Mahmood
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1607-1611; DOI: https://doi.org/10.2967/jnumed.116.173930
  • You have access
    Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma
    Katja Behling, William F. Maguire, José Carlos López Puebla, Shanna R. Sprinkle, Alessandro Ruggiero, Joseph O'Donoghue, Philip H. Gutin, David A. Scheinberg and Michael R. McDevitt
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1576-1582; DOI: https://doi.org/10.2967/jnumed.115.171371
  • You have access
    A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects
    Chao Zhang, Richard Kimura, Lotfi Abou-Elkacem, Jelena Levi, Lingyun Xu and Sanjiv Sam Gambhir
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1629-1634; DOI: https://doi.org/10.2967/jnumed.115.169383
  • You have access
    Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation
    Shichun Peng, Yilong Ma, Joseph Flores, Michael Cornfeldt, Branka Mitrovic, David Eidelberg and Doris J. Doudet
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1591-1598; DOI: https://doi.org/10.2967/jnumed.115.161513
  • You have access
    (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy
    Ana P. Kiess, Il Minn, Ganesan Vaidyanathan, Robert F. Hobbs, Anders Josefsson, Colette Shen, Mary Brummet, Ying Chen, Jaeyeon Choi, Eftychia Koumarianou, Kwamena Baidoo, Martin W. Brechbiel, Ronnie C. Mease, George Sgouros, Michael R. Zalutsky and Martin G. Pomper
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1569-1575; DOI: https://doi.org/10.2967/jnumed.116.174300
  • You have access
    Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme
    Laigao Chen, Nabeel Nabulsi, Mika Naganawa, Kenneth Zasadny, Marc B. Skaddan, Lei Zhang, Soheila Najafzadeh, Shu-fei Lin, Christopher J. Helal, Tracey L. Boyden, Cheng Chang, Jim Ropchan, Richard E. Carson, Anabella Villalobos and Yiyun Huang
    Journal of Nuclear Medicine September 1, 2016, 57 (9) 1448-1453; DOI: https://doi.org/10.2967/jnumed.115.171454

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 174
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire